Guardian Pharmacy Services, Inc.
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -0.62% | -897.70% | -68.77% | 293.49% | 2.74% |
Total Depreciation and Amortization | 9.31% | 7.68% | 8.78% | 7.95% | 11.30% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 133.46% | 400.08% | 218.33% | -32.42% | -1,040.78% |
Change in Net Operating Assets | -106.30% | -440.58% | -131.53% | 18.12% | 314.89% |
Cash from Operations | 53.48% | -114.61% | -20.97% | 7.67% | 42.70% |
Capital Expenditure | -62.90% | -20.13% | 11.11% | 9.75% | 38.08% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -125.08% | -- | -- | 100.00% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -92.14% | -51.39% | 188.92% | 39.11% | 876.44% |
Cash from Investing | -477.51% | -50.28% | -111.47% | -129.87% | 78.35% |
Total Debt Issued | -100.00% | 9.03% | -8.18% | 9.39% | -3.38% |
Total Debt Repaid | 35.39% | -11.40% | 15.15% | 7.41% | 4.77% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -88.43% | 24.50% | -92.52% | -326.26% |
Other Financing Activities | 29.55% | -1,505.34% | 24.88% | -17.17% | -76.70% |
Cash from Financing | -263.62% | 542.77% | 48.89% | 27.24% | -182.50% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -24,955.73% | 74,439.58% | 305.15% | 1,222.86% | -34.83% |